Standout Papers

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vac... 1983 2026 1997 2011 466
  1. Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups (1983)
    John B. Robbins, Robert Austrian et al. The Journal of Infectious Diseases

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

Direct radical functionalization of native sugars
2024 StandoutNature
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
2020 StandoutScience
2 intermediate papers

Works of James C. Parke being referenced

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups
1983 Standout
Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies
1973

Author Peers

Author Last Decade Papers Cites
James C. Parke 1249 1042 220 259 29 1.8k
Betsy Kuipers 1103 1333 343 136 47 1.7k
J B Robbins 752 675 388 217 30 2.0k
Brunella Brunelli 1203 1402 224 90 33 1.9k
L van Alphen 927 1083 210 218 65 1.9k
D. M. Granoff 1186 1277 251 463 28 1.7k
John K. Whisnant 703 418 477 147 41 1.6k
L Nencioni 574 731 620 273 52 1.8k
Keith Cartwright 2115 1959 215 57 46 2.5k
Viena Karanko 1431 1141 243 192 12 1.8k
Jutta M. Loeffler 520 585 355 126 19 1.9k

All Works

Loading papers...

Rankless by CCL
2026